silk eczema relief cream - product evaluation protocol report (group 1 2)
Post on 03-Jun-2018
221 Views
Preview:
TRANSCRIPT
-
8/12/2019 Silk Eczema Relief Cream - Product Evaluation Protocol Report (Group 1 2)
1/21
Reference: SOP QAC-002-00
Page | 1
4/26 Coromandel Parade, Blackwood, SA 5051, Australia
Ph.: (+61) 8 8463 0990 Fax: (+61) 8 8278 6360
www.personalcarescience.com.au info@personalcarescience.com.au
Product Evaluation Protocol and Report
Company:Belle Natural Skincare
Product:Silk Eczema Relief Cream (SERC)
Formula Reference:BEL001-0
Product evaluation ID:PE005
Revision:004
Supersedes:New
Test Facility: Institute of Personal Care Science
4/26 Coromandel Parade
Blackwood, SA 5051
Australia
Protocol Prepared By:Mariza Ovalle
CONTENTS
Particular Page1.0 INTRODUCTION 2
1.1 Objectives of the protocol 2
1.2 Objectives of the product evaluation 2
1.3 Outline Considerations 2
2.0 MATERIALS AND METHOD 2
2.1 Products 2
2.2 Equipment 3
2.3 Participants and Evaluators 3
2.4 Method 3
2.5 Procedure 4
3.0 OPERATION 5
4.0 VALIDITY 5
5.0 RESULTS 5
6.0 CONCLUSIONS 14
Annex 1Participants List 15
Annex 2Participant Details Form 16
Annex 3Informed Consent Form 17
Annex 4Instructions Card 19
Annex 5Score System Record 20
-
8/12/2019 Silk Eczema Relief Cream - Product Evaluation Protocol Report (Group 1 2)
2/21
Reference: SOP QAC-002-00
Page | 2
4/26 Coromandel Parade, Blackwood, SA 5051, Australia
Ph.: (+61) 8 8463 0990 Fax: (+61) 8 8278 6360
www.personalcarescience.com.au info@personalcarescience.com.au
1.0 INTRODUCTION1.1 Objectives of the ProtocolThe following protocol is designed to detail the single-blind comparative-group evaluation for Belle
Natural Skincaresproduct, SERC, with Formula Reference BEL001-0. This protocol is in accordance
with clinical testing guidelines and will describe how the product evaluation testing was be
conducted and analysed with required acceptance criteria.
1.2 Objectives of the Product EvaluationThe purpose of this evaluation was to determine the performance of Belle Natural Skincare SERC
against Placebo in:
The management of eczema.
The symptomatic relief of eczema.
Hypothesis 1: Belle Natural Skincare SERC has a significant better activity than Placebo in the
management and symptomatic relief of eczema.
1.3 Outline ConsiderationsThis study was designed as a single-blind group-comparative evaluation, involving 2 groups randomly
selected to receive treatment with:
Belle Natural Skincare SERC
Placebo
The study involved the three times daily application of the assigned product on the affected areas. It
was conducted over a period of 28 days, involving 54 participants divided in 2 groups:
Belle Natural Skincare SERC: 28 participants
Placebo: 26 participants
During the 28 days testing, evaluations were made on the following time points:
T = 0 (Initial)
T = 7 days T = 28 days
2.0 MATERIALS AND METHOD2.1 ProductsThe products used for the evaluation were:
Belle Natural Skincare SERCProduct A
PlaceboProduct B
-
8/12/2019 Silk Eczema Relief Cream - Product Evaluation Protocol Report (Group 1 2)
3/21
Reference: SOP QAC-002-00
Page | 3
4/26 Coromandel Parade, Blackwood, SA 5051, Australia
Ph.: (+61) 8 8463 0990 Fax: (+61) 8 8278 6360
www.personalcarescience.com.au info@personalcarescience.com.au
1 sample per participant was necessary to conduct the evaluations. The samples were labelled as
Product A or Product B in order to avoid bias. Participants were randomly provided with the product
to be used.
The products were applied only in the affected areas of the following body groups, hereafter known
as the application areas:
Head and neck
Upper limbs
Trunk
Lower limbs
2.2 EquipmentIn order to conduct the product evaluations, the following equipment was required:
Digital camera
Computer
2.3 Participants and Evaluators54 participants from all ages and both sexes were recruited, which should have been medically
diagnosed with atopic eczema. Any other topical treatment being used was discontinued during the
evaluation.
Each participant was assigned with a Participant Code, which was registered in a Participant List(Annex 1); the product (A or B) provided to each participant was also registered in this list.
Participants details were registered in a Participant Details Form (Annex 2), which will remain
confidential at IPCS. A trained evaluator from IPCS labelled the products and randomly assigned
them to the participants. This evaluator also conducted the tests and assessed the results, according
to SOP QAC-002.
An Informed Consent Form (Annex 3) with an information sheet and a certificate of consent was
signed by each participant. An Instructions Card (Annex 4) with the specific steps to follow was given
to each participant.
2.4 Methods2.4.1 EASI Score System tool used to measure the severity and extent of atopic eczema
(Eczema Area and Severity Index) and to evaluate the performance of Belle Natural
Skincare SERC against Placebo.
Four body regions are visually assessed: (1) Head and Neck, (2) Upper Limbs, (3) Trunk,
and (4) Lower Limbs.
-
8/12/2019 Silk Eczema Relief Cream - Product Evaluation Protocol Report (Group 1 2)
4/21
Reference: SOP QAC-002-00
Page | 4
4/26 Coromandel Parade, Blackwood, SA 5051, Australia
Ph.: (+61) 8 8463 0990 Fax: (+61) 8 8278 6360
www.personalcarescience.com.au info@personalcarescience.com.au
The intensity of redness, thickness, scratching and lichenification of eczema is assessed
for each body region as none, mild, moderate and severe. The approximate percentage of
area affected by eczema is also calculated for each body region. Both intensity and area
values are then used to calculate the EASI Score.
Results were recorded in an excel spread sheet (Annex 5) and are supported with pictures
taken with a digital camera.
2.4.2 Interviewconducted to support the performance of Belle Natural Skincare SERC against
Placebo in the symptomatic relief of eczema.
2.5 Procedure
Initial (T = 0)
2.5.1 The areas of evaluation were clean and free of any substance (lotion, oil, fragrance, etc.).
2.5.2 The evaluator conducted and recorded the corresponding tests to each participant
according to SOP QAC-002.
2.5.3 The evaluator gave the instructions to each participant, along with the corresponding
samples and an Instructions Card (Annex 4) with detail of the steps to follow.
2.5.4 Participants should follow these steps and contact IPCS if any problem or reaction
occurred with the application of the products.
After 7 Days (T = 7)
2.5.5 Participants had to present at IPCS after 7 days of the initial test with the remaining
sample.
2.5.6 The evaluator conducted and recorded the corresponding tests according to SOP QAC-
002.
2.5.7 The evaluator reviewed the remaining samples in order to determine if the products
were being applied appropriately or if more samples were necessary to continue the trial.
2.5.8 Participants must continue the application of the products following the steps detailed on
the Instructions Card.
After 28 Days (T = 28)
2.5.9 Participants had to present at IPCS after 28 days of the initial test with any remaining
sample.
2.5.10The evaluator conducted and recorded the corresponding tests to each participant
according to SOP QAC-002.
2.5.11The evaluator reviewed the remaining samples in order to determine if the products
were applied appropriately.
-
8/12/2019 Silk Eczema Relief Cream - Product Evaluation Protocol Report (Group 1 2)
5/21
Reference: SOP QAC-002-00
Page | 5
4/26 Coromandel Parade, Blackwood, SA 5051, Australia
Ph.: (+61) 8 8463 0990 Fax: (+61) 8 8278 6360
www.personalcarescience.com.au info@personalcarescience.com.au
3.0 OPERATIONRecord was made to confirm that each step was carried out on each participant exactly as stated
above.
4.0 VALIDITYResults were reviewed and assessed by the evaluator according to SOP QAC-002.
Results were tabulated and percentage of improvement was determined in order to accept or reject
the hypotheses proposed on section 1.2 of this protocol.
5.0 RESULTS54 participants started the evaluation, which were divided in two groups and were randomly
assigned to receive Product A (Belle Natural Skincare SERC/) or Product B (Placebo).
After 7 days,
42 participants presented at IPCS for evaluation.
After 28 days,
39 participants presented at IPCS for evaluation and completed the evaluation.
In summary,
39 participants finalised the Product Evaluation, from which:
- 20participants received Product A
- 19 participants received Product B
15 participants dropped the test.
-
8/12/2019 Silk Eczema Relief Cream - Product Evaluation Protocol Report (Group 1 2)
6/21
Reference: SOP QAC-002-00
Page | 6
4/26 Coromandel Parade, Blackwood, SA 5051, Australia
Ph.: (+61) 8 8463 0990 Fax: (+61) 8 8278 6360
www.personalcarescience.com.au info@personalcarescience.com.au
5.1 EASI Score SystemThe EASI Score System was used to measure the severity and extent of atopic eczema and to
evaluate the performance of Product A against Product B. The following results were obtained.
Table # 1EASI Score Value by Participant
Participant Code AgeProduct
Assigned
EASI Score
Initial After 7 Days After 28 Days
PE005-A 9 y.o. A 12.2 11.0 7.6
PE005-B 19 y.o. A 15.0 12.2 9.0
PE005-C 19 y.o. B 1.8 2.7 2.7
PE005-D 17 y.o. A 2.8 2.4 1.6
PE005-E 5 y.o. A 16.6 13.8 0.0
PE005-F 21 y.o. A 36.4 34.2 PDT
PE005-G 18 y.o. B 2.4 2.8 PDT
PE005-H 4 m.o. A 9.8 PNE PNE
PE005-I 2 y.o. A 4.8 4.2 3.0
PE005-J 43 y.o. B 2.0 1.2 1.6
PE005-K 51 y.o. B 3.2 3.2 3.6
PE005-L 43 y.o. B 0.4 0.8 PDT
PE005-M 31 y.o. A 1.0 1.0 0.6PE005-N 25 y.o. A 6.4 PNE 3.0
PE005-O 12 y.o. B 3.2 3.2 3.2
PE005-P 17 y.o. A 9.0 6.6 3.9
PE005-Q 43 y.o. A 1.4 PNE 0.4
PE005-R 6 m.o. A 0.9 PNE 0.6
PE005-S 41 y.o. B 1.2 0.6 0.0
PE005-T 4 y.o. B 2.4 2.4 PDT
PE005-U 40 y.o. B 1.8 2.1 3.3
PE005-V 30 y.o. B 1.6 1.6 1.6PE005-W 63 y.o. A 3.6 2.8 0.8
PE005-X 4 y.o. A 1.3 PDT PDT
PE005-Z 15 y.o. B 2.0 PDT PDT
PE005-AA 41 y.o. B 1.8 PDT PDT
PE005-AB 11 m.o. A 22.5 21.5 14.0
PE005-AC 36 y.o. A 16.8 14.2 17.4
PE005-AD 57 y.o. A 2.4 2.0 PNE
PE005-AE 54 y.o. A 1.6 PNE PNE
-
8/12/2019 Silk Eczema Relief Cream - Product Evaluation Protocol Report (Group 1 2)
7/21
Reference: SOP QAC-002-00
Page | 7
4/26 Coromandel Parade, Blackwood, SA 5051, Australia
Ph.: (+61) 8 8463 0990 Fax: (+61) 8 8278 6360
www.personalcarescience.com.au info@personalcarescience.com.au
PE005-AF 84 y.o. A 8.2 PNE PNE
PE005-AG 12 y.o. A 0.6 0.6 0.0
PE005-AH 21 y.o. A 2.8 1.6 1.2
PE005-AI 2 y.o. B 4.2 PNE PNE
PE005-AJ 21 y.o. A 0.8 0.6 PNE
PE005-AK 28 y.o. B 3.0 3.6 3.0
PE005-AL 18 y.o. A 4.8 3.2 0.0
PE005-AM 53 y.o. A 2.6 2.0 0.0
PE005-AN 36 y.o. A 2.6 1.0 0.0
PE005-AO 38 y.o. B 1.6 3.0 3.0
PE005-AP 36 y.o. B 0.7 1.1 1.1
PE005-AQ 29 y.o. A 3.2 0.4 PNE
PE005-AR 45 y.o. A 1.0 2.4 0.0
PE005-AS 29 y.o. B 1.4 1.3 1.6
PE005-AT 44 y.o. B 2.6 1.8 2.6
PE005-AU 25 y.o. A 1.1 0.9 0.1
PE005-AV 49 y.o. B 3.4 3.8 3.8
PE005-AW 41 y.o. B 1.4 1.8 1.8
PE005-AX 27 y.o. B 1.3 PNE PNE
PE005-AY 41 y.o. B 1.4 PNE 1.4
PE005-AZ 29 y.o. B 0.6 0.5 0.5
PE005-BA 65 y.o. B 1.2 PNE 1.2
PE005-BB 30 y.o. B 1.6 1.6 1.6PE005-BC 30 y.o. B 1.1 1.1 1.1
y.o.years old
m.o.months old
PDTParticipant dropped test
PNEParticipant not evaluated (didnt present
at IPCS for evaluation)
The percentage of improvement of the EASI Scores was also determined for each participant
and product. The following results were obtained:
Table # 2Percentage of Improvement by Participant
Participant Code Product AssignedPercentage of Improvement
After 7 Days After 28 Days
PE005-A A 9.84 37.30
PE005-B A 18.67 40.00
PE005-C B -50.00 -50.00
PE005-D A 14.29 42.86
PE005-E A 16.87 100.00
PE005-F A 6.04 PDT
-
8/12/2019 Silk Eczema Relief Cream - Product Evaluation Protocol Report (Group 1 2)
8/21
Reference: SOP QAC-002-00
Page | 8
4/26 Coromandel Parade, Blackwood, SA 5051, Australia
Ph.: (+61) 8 8463 0990 Fax: (+61) 8 8278 6360
www.personalcarescience.com.au info@personalcarescience.com.au
PE005-G B -16.67 PDT
PE005-H A PNE PNE
PE005-I A 12.50 37.50
PE005-J B 40.00 20.00
PE005-K B 0.00 -12.50
PE005-L B -100.00 PDT
PE005-M A 0.00 40.00
PE005-N A PNE 53.13
PE005-O B 0.00 0.00
PE005-P A 26.67 56.67
PE005-Q A PNE 71.43
PE005-R A PNE 33.33
PE005-S B 50.00 100.00
PE005-T B 0.00 PDT
PE005-U B -16.67 -83.33
PE005-V B 0.00 0.00
PE005-W A 22.22 77.78
PE005-X A PDT PDT
PE005-Z B PDT PDT
PE005-AA B PDT PDT
PE005-AB A 4.44 37.78
PE005-AC A 15.48 -3.57
PE005-AD A 16.67 PNEPE005-AE A PNE PNE
PE005-AF A PNE PNE
PE005-AG A 0.00 100.00
PE005-AH A 42.86 57.14
PE005-AI B PNE PNE
PE005-AJ A 25.00 PNE
PE005-AK B -20.00 0.00
PE005-AL A 33.33 100.00
PE005-AM A 23.08 100.00PE005-AN A 61.54 100.00
PE005-AO B -87.50 - 87.50
PE005-AP B -57.40 -57.40
PE005-AQ A 87.50 PNE
PE005-AR A 0.00 100.00
PE005-AS B 7.14 -14.29
PE005-AT B 30.77 0.00
PE005-AU A 18.18 90.91
-
8/12/2019 Silk Eczema Relief Cream - Product Evaluation Protocol Report (Group 1 2)
9/21
Reference: SOP QAC-002-00
Page | 9
4/26 Coromandel Parade, Blackwood, SA 5051, Australia
Ph.: (+61) 8 8463 0990 Fax: (+61) 8 8278 6360
www.personalcarescience.com.au info@personalcarescience.com.au
PE005-AV B -11.76 -11.76
PE005-AW B -28.57 -28.57
PE005-AX B PNE PNE
PE005-AY B PNE 0.00
PE005-AZ B 25.00 25.00
PE005-BA B PNE 0.00
PE005-BB B 0.00 0.00
PE005-BC B 0.00 0.00
PNEParticipant not evaluated (didnt present at IPCS for evaluation)
PDTParticipant dropped test
Table # 3Average Percentage of Improvement by Product
Product AssignedAverage Percentage of Improvement
After 7 Days After 28 Days
A 21.68 63.61
B -11.78 -10.54
Graph # 1Average Percentage of Improvement by Product
-20.00
-10.00
0.00
10.00
20.00
30.00
40.00
50.00
60.00
70.00
Silk Eczema Relief Cream
(SERC)/Natzema
Placebo
Day 7 Day 28
-
8/12/2019 Silk Eczema Relief Cream - Product Evaluation Protocol Report (Group 1 2)
10/21
Reference: SOP QAC-002-00
Page | 10
4/26 Coromandel Parade, Blackwood, SA 5051, Australia
Ph.: (+61) 8 8463 0990 Fax: (+61) 8 8278 6360
www.personalcarescience.com.au info@personalcarescience.com.au
5.2Visual Testing
Pictures were taken to each participant to support the values assigned in the EASI Score System.
The following pictures show the most remarkable cases.
Picture # 1Participant PE005-B (Product A)
Initial After 7 Days After 28 Days
A reduction in scratching and lichenification was seen after 7 and 28 days of application of
Product A.
Picture # 2Participant PE005-I (Product A)
Initial After 7 Days After 28 Days
A reduction in redness, thickness, lichenification and area affected was seen after 7 and 28
days of application of Product A.
-
8/12/2019 Silk Eczema Relief Cream - Product Evaluation Protocol Report (Group 1 2)
11/21
Reference: SOP QAC-002-00
Page | 11
4/26 Coromandel Parade, Blackwood, SA 5051, Australia
Ph.: (+61) 8 8463 0990 Fax: (+61) 8 8278 6360
www.personalcarescience.com.au info@personalcarescience.com.au
Picture # 3Participant PE005-K (Product B)
Initial After 7 Days After 28 Days
An increase in thickness was seen after 7 and 28 days of application of Product B.
Picture # 4Participant PE005-N (Product A)
Initial After 28 Days
A reduction in redness and area affected was seen after 28 days of application of Product A;
the participant couldnt attend at his 7 days appointment, therefore results are not available.
-
8/12/2019 Silk Eczema Relief Cream - Product Evaluation Protocol Report (Group 1 2)
12/21
Reference: SOP QAC-002-00
Page | 12
4/26 Coromandel Parade, Blackwood, SA 5051, Australia
Ph.: (+61) 8 8463 0990 Fax: (+61) 8 8278 6360
www.personalcarescience.com.au info@personalcarescience.com.au
Picture # 5Participant PE005-U (Product B)
Initial After 7 Days After 28 Days
An increase in thickness, scratching and lichenification was seen after 7 and 28 days of
application of Product B.
Picture # 6Participant PE005-W (Product A)
Initial After 7 Days After 28 Days
A reduction in redness, thickness, lichenification and area affected, in both face and upper
limbs, was seen after 7 and 28 days of application of Product A.
-
8/12/2019 Silk Eczema Relief Cream - Product Evaluation Protocol Report (Group 1 2)
13/21
Reference: SOP QAC-002-00
Page | 13
4/26 Coromandel Parade, Blackwood, SA 5051, Australia
Ph.: (+61) 8 8463 0990 Fax: (+61) 8 8278 6360
www.personalcarescience.com.au info@personalcarescience.com.au
Picture # 7Participant PE005-AB (Product A)
Initial After 7 Days After 28 Days
A reduction in redness, thickness, scratching, lichenification and area affected was seen after
28 days of application of Product A.
Picture # 8Participant PE005-AH (Product A)
Initial After 28 Days
A reduction in redness and area affected was seen after 28 days of application of Product A.
-
8/12/2019 Silk Eczema Relief Cream - Product Evaluation Protocol Report (Group 1 2)
14/21
Reference: SOP QAC-002-00
Page | 14
4/26 Coromandel Parade, Blackwood, SA 5051, Australia
Ph.: (+61) 8 8463 0990 Fax: (+61) 8 8278 6360
www.personalcarescience.com.au info@personalcarescience.com.au
5.3 Interviews
An interview was conducted to each participant to determine the performance of the product
being used and to support the results obtained with the EASI Score System.
In general, participants using Product A could notice a reduction of redness and itchiness within
time. A few participants experienced the opposite and therefore decided to drop the test.
By the other hand, participants using Product B experienced an increase of redness and
itchiness or no difference at all; therefore some participants decided to drop the test.
6.0 CONCLUSIONSFrom the 54 participants that started the test, 38 completed the evaluation.
In average, Silk Eczema Relief Cream (SERC) provided a 16.14%improvement in the EASI Score
after 7 days of treatment and a 90.88%improvement after 28 days.
Placebo provided negative results: -13.09%improvement after 7 days and -3.69%improvement
after 28 days.
In general, participants using Silk Eczema Relief Cream (SERC) experienced a symptomatic relief
of eczema by reducing irritation and redness. In the opposite, participants using Placebo
experienced an increase on redness and itchiness or no effect at all.
With these results, it can be concluded that Silk Eczema Relief Cream (SERC) has a significant
better activity than Placebo in the management and symptomatic relief of eczema.
-
8/12/2019 Silk Eczema Relief Cream - Product Evaluation Protocol Report (Group 1 2)
15/21
Reference: SOP QAC-002-00
Page | 15
4/26 Coromandel Parade, Blackwood, SA 5051, Australia
Ph.: (+61) 8 8463 0990 Fax: (+61) 8 8278 6360
www.personalcarescience.com.au info@personalcarescience.com.au
ANNEX 1
PARTICIPANTS LIST
Number Participant Code Group Details
1 PE005-A
Age
Sex
Medically diagnosed atopic eczema
Duration of disease
Treatments being taken
2 PE005-B
Age
Sex
Medically diagnosed atopic eczema
Duration of disease
Treatments being taken
3 PE005-C
Age
Sex
Medically diagnosed atopic eczema
Duration of disease
Treatments being taken
4
Age
Sex
Medically diagnosed atopic eczema
Duration of disease
Treatments being taken
5
Age
Sex
Medically diagnosed atopic eczema
Duration of disease
Treatments being taken
-
8/12/2019 Silk Eczema Relief Cream - Product Evaluation Protocol Report (Group 1 2)
16/21
Reference: SOP QAC-002-00
Page | 16
4/26 Coromandel Parade, Blackwood, SA 5051, Australia
Ph.: (+61) 8 8463 0990 Fax: (+61) 8 8278 6360
www.personalcarescience.com.au info@personalcarescience.com.au
ANNEX 2
PARTICIPANT DETAILS FORM
Number Participant Code Group Details
Name
Contact details
Age
Sex
Medically diagnosed atopic eczema
Duration of disease
Treatments being taken
Symptoms
Other details
-
8/12/2019 Silk Eczema Relief Cream - Product Evaluation Protocol Report (Group 1 2)
17/21
Reference: SOP QAC-002-00
Page | 17
4/26 Coromandel Parade, Blackwood, SA 5051, Australia
Ph.: (+61) 8 8463 0990 Fax: (+61) 8 8278 6360
www.personalcarescience.com.au info@personalcarescience.com.au
ANNEX 3
INFORMED CONSENT FORM
This Informed Consent Form is for men and women who attend the Institute of Personal Care Science and whoagree to participate in the evaluation to determine the performance Belle Natural Eczema Relief Cream in the
management and symptomatic relief of eczema.
This Informed Consent has two parts:
I. Information Sheet
II. Certificate of Consent
You will be given a copy of the full Informed Consent Form.
PART I: Information Sheet
Introduction
The Institute of Personal Care Science is conducting a research on eczema, which is very common in Australia. We
will provide you information and invite you to be part of this research.
Please let us know if you have any question or if you need more explanation on the research we are conducting.
Purpose
This research is being conducted to determine the performance of Belle Natural Eczema Relief Cream in the
management and symptomatic relief of eczema.
Type of Research Intervention
This research will involve the topical application of the product in the affected areas, three times daily and for a
period of 28 days.
Participant Selection
We are inviting all people that have been medically diagnosed with atopic eczema.
Voluntary Participation
Your participation in this research is entirely voluntary. It is your choice whether to participate or not. If you
decide to participate, you may change your mind later and stop participating even if you agreed earlier.
Information on the Products
The products we are testing are all natural and do not contain any irritant ingredients. No side-effects, toxicity
and adverse reactions are being expected; however if you encounter any problem, please communicate
immediately with us.
-
8/12/2019 Silk Eczema Relief Cream - Product Evaluation Protocol Report (Group 1 2)
18/21
Reference: SOP QAC-002-00
Page | 18
4/26 Coromandel Parade, Blackwood, SA 5051, Australia
Ph.: (+61) 8 8463 0990 Fax: (+61) 8 8278 6360
www.personalcarescience.com.au info@personalcarescience.com.au
Procedures and Protocol
If you agree to participate in this research, we will provide you with an Instructions Card with more details of the
procedure to follow. Please let us know if you have any question or if you need more explanation on the steps
you need to follow.
Because we need to determine the performance of the product in the management and symptomatic relief of
eczema, we will compare it against placebo (a product with no active ingredients).
To do this, we will put people taking part in this research into two groups. The groups will be randomly selected.
Participants in one group will be given with the test product while participants in the other group will be given
with the placebo. It is important that you dont know which of the two products are given in order to avoid that
results are influenced by what you think or hope might happen. We will be looking after you and the other
participants very carefully during the evaluation; if we are concerned about the effects of any of the products, we
will stop immediately its use.
Confidentiality
We will not be sharing your personal details with anyone and will be kept confidential. Results about you will not
be identified by your name but by a number and will only be provided in this manner.
The knowledge that we get from doing this research will be shared with you before it is made widely available to
the public. Confidential information will not be shared.
Who to Contact
If you encounter any problem or reaction with the use of this product, please stop using immediately and contactus at:
Institute of Personal Care Science (IPCS)
Phone: 08 8463 0990
Email:info@personalcarescience.com.au
PART II: Certificate of Consent
By signing below you acknowledge that you have been informed of the nature of the test and what is required of
your involvement. The procedure involved in the test has been explained to you, as have the potential and typesof any side effects. You have also been informed that your participation in this test will remain private; and the
requirement to keep all information regarding this test confidential. You agree not to disclose any information
pertaining to this test or your involvement to any third party, without prior consent from the Institute of Personal
Care Science. You also acknowledge that you are over 18 years of age and capable of consenting to your
participation or the one of your child.
Name Signature Date
mailto:info@personalcarescience.com.aumailto:info@personalcarescience.com.aumailto:info@personalcarescience.com.aumailto:info@personalcarescience.com.au -
8/12/2019 Silk Eczema Relief Cream - Product Evaluation Protocol Report (Group 1 2)
19/21
Reference: SOP QAC-002-00
Page | 19
4/26 Coromandel Parade, Blackwood, SA 5051, Australia
Ph.: (+61) 8 8463 0990 Fax: (+61) 8 8278 6360
www.personalcarescience.com.au info@personalcarescience.com.au
ANNEX 4
INSTRUCTIONS CARD
Dear Participant,
Thanks for participating on this evaluation!
The objective of this evaluation is to determine the performance of a product in the management and
symptomatic relief of eczema. Please follow these instructions accurately in order to get the best possible results.
The evaluation will be conducted in a period of 28 days divided in 3 time points: initial, after 7 days and after 28
days.
At the beginning of the evaluation you will be given with one container of product.
Instructions
1. Please follow these instructions accurately.
2. Before applying the product, please make sure that the areas of application are clean and free of any other
substance such as body lotion, hand cream, body oil, perfume, etc.
3. Apply approximately 12 fingertips of product in the affected areas of the following body regions:
Head and neck
Upper limbs
Trunk
Lower limbs
4. Allow to dry for 1 minute before putting any clothes on.
5. Do not use any other treatment while conducting the trial.
6. After 7 days of application, please present at IPCS with your sample.
7. Your evaluator will conduct the same tests performed at the beginning of this evaluation and will provide you
with instructions for the following 21 days.
8. If you encounter any problem or reaction with the use of this product, please stop using immediately and
contact us at:
Institute of Personal Care Science (IPCS)
Phone: 08 8463 0990
Email:info@personalcarescience.com.au
Thanks again for participating in this evaluation! Your next appointment is on: date of next appointment
mailto:info@personalcarescience.com.aumailto:info@personalcarescience.com.aumailto:info@personalcarescience.com.aumailto:info@personalcarescience.com.au -
8/12/2019 Silk Eczema Relief Cream - Product Evaluation Protocol Report (Group 1 2)
20/21
Reference: SOP QAC-002-00
Page | 20
4/26 Coromandel Parade, Blackwood, SA 5051, Australia
Ph.: (+61) 8 8463 0990 Fax: (+61) 8 8278 6360
www.personalcarescience.com.au info@personalcarescience.com.au
ANNEX 5
EASI SCORE SYSTEM RECORD
INTENSITY AREA
Absent 0 Nil 0 50 - 69% 4
Mild 1 1 - 9% 1 70 - 89% 5
Moderate 2 10 - 29% 2 90 - 100% 6
Severe 3 30 - 49% 3
INITIAL
Body Region Intensity Score A B C
Head and Neck
Redness
0 0.0 0.0
Thickness
Scratching
Lichenification
Area
Upper Limbs
Redness
0 0.0 0.0
Thickness
Scratching
Lichenification
Area
Trunk
Redness
0 0.0 0.0
Thickness
Scratching
Lichenification
Area
Lower Limbs
Redness
0 0.0 0.0
Thickness
Scratching
Lichenification
Area
TOTAL EASI SCORE 0
AFTER 7 DAYS
Body Region Intensity Score A B C
Head and Neck
Redness
0 0.0 0.0
Thickness
Scratching
Lichenification
Area
-
8/12/2019 Silk Eczema Relief Cream - Product Evaluation Protocol Report (Group 1 2)
21/21
Reference: SOP QAC-002-00
Page | 21
4/26 Coromandel Parade, Blackwood, SA 5051, Australia
Ph : (+61) 8 8463 0990 Fax: (+61) 8 8278 6360
Upper Limbs
Redness
0 0.0 0.0
Thickness
Scratching
Lichenification
Area
Trunk
Redness
0 0.0 0.0
Thickness
Scratching
Lichenification
Area
Lower Limbs
Redness
0 0.0 0.0
Thickness
Scratching
LichenificationArea
TOTAL EASI SCORE 0
AFTER 28 DAYS
Body Region Intensity Score A B C
Head and Neck
Redness
0 0.0 0.0
Thickness
Scratching
LichenificationArea
Upper Limbs
Redness
0 0.0 0.0
Thickness
Scratching
Lichenification
Area
Trunk
Redness
0 0.0 0.0
Thickness
Scratching
Lichenification
Area
Lower Limbs
Redness
0 0.0 0.0
Thickness
Scratching
Lichenification
Area
TOTAL EASI SCORE 0
top related